The m⁶A Writer RBM15 Drives the Growth of Triple-Negative Breast Cancer Cells through the Stimulation of Serine and Glycine Metabolism

Scientists identified significantly elevated levels of RNA-binding motif protein 15 (RBM15), an m6A writer, in basal-like breast cancer (BC) patients compared to nonbasal-like BC patients and linked this increase to worse clinical outcomes.